SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Starling Oncology, Inc. backtest

10 trend-following strategies were compared on the full daily history of Starling Oncology, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 40.7%, MDD -39.1%).

Data 2020-06-04 ~ 2026-07-31daily bars 1,547 (6.2 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -10.7%, drawdown -98.8%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 89.4%, MDD -50.4%, Sharpe 1.30, 35% exposure.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 100.1%p higher than buy and hold, while drawdown improves by 48.4%p (CAGR 40.7%, MDD -39.1%, exposure 16%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=21, threshold=19
89.4%-50.4%1.301.7751.0x3935%
ROC 모멘텀
n=63, threshold=0.12
58.7%-55.5%1.071.0617.1x3728%
볼린저 밴드 돌파
n=59, k=3.1
40.7%-39.1%0.951.048.2x816%
SMA 크로스오버
fast=22, slow=87
47.6%-55.3%0.930.8611.0x1738%
EMA 크로스오버
fast=34, slow=50
47.0%-55.3%0.920.8510.7x1940%
Donchian 채널 돌파
entryN=80, exitN=57
39.9%-50.8%0.860.787.9x930%
Keltner 채널 돌파
emaPeriod=37, atrPeriod=22, mult=1.7
37.4%-45.3%0.850.837.1x3228%
Parabolic SAR
step=0.015, maxStep=0.16
41.2%-63.0%0.840.658.4x10050%
MACD
fast=11, slow=51, signal=14
42.5%-85.4%0.840.508.9x6657%
Supertrend
period=18, mult=4.4
32.6%-71.8%0.760.455.7x1738%
Buy and hold-10.7%-98.8%0.37-0.110.5x1100%
0.1 1x 10x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -50.4% (2021-12-28 → 2022-06-07), recovered after 562 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next